AtriCure was formed by a team with extensive experience in the medical device industry. The company is focused on developing innovative products using proprietary technology that provides doctors alternative, expedient methods to ablate tissue during surgical procedures.
WEST CHESTER, Ohio, Feb 05, 2010 (BUSINESS WIRE) -- AtriCure, Inc. (NASDAQ:ATRC), a medical device company and a leader in
cardiac surgical ablation products, will release its financial results
for the fourth quarter and year ended December 31, 2009 on Thursday,
February 18, 2010.
AtriCure will host a conference call at 10:00 a.m. Eastern Time on
Thursday, February 18, 2010 to discuss its fourth quarter and full year
2009 financial results. A live web cas...
WEST CHESTER, Ohio, Feb 02, 2010 (BUSINESS WIRE) -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it has executed
a definitive agreement with the Department of Justice (DOJ) and the
Office of Inspector General of the Department of Health and Human
Services to resolve the issues raised in the DOJ's investigation and the
related qui tam complaint regarding the marketing of the ...
WEST CHESTER, Ohio--(BUSINESS WIRE)--Nov. 23, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it will
participate in the Piper Jaffray Healthcare Conference at the New York
Palace Hotel on Tuesday, December 1, 2009. David J. Drachman, President
and Chief Executive Officer, is scheduled to present at 4:00 p.m.
Eastern Time.
A live audio webcast and ...
Third Quarter Highlights
Non-GAAP operating loss improves 63% to a record $0.7 million
Record adjusted EBITDA of $0.7 million
Record non-GAAP net loss per share of $0.06
Year-to-date cash provided by operations of $0.3 million
European approval and initial launch of the AtriClip™ System
Settlement reserve established related to DOJ investigation
WEST CHESTER, Ohio--(BUSINESS WIRE)--Nov. 4, 2009-- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surg...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
